Slide background
INNOVATING targeting
Slide background
INNOVATING targeting


Philogen is a Swiss-Italian integrated biotechnology company founded in 1996, with the mission to develop innovative biopharmaceuticals for the treatment of angiogenesis-related disorders. Angiogenesis, i.e. the formation ... Read all


Philogen S.p.A announced the launch of a pivotal trial in patients with Stage IIIB/C melanoma, following promising results obtained in a Phase II study with an innovative immunotherapeutic approach. Siena, 21st January...

Read all


Philogen is a fully integrated company active in the discovery, GMP production and clinical development of immunomodulatory biopharmaceuticals. We have a leading position in the field of antibody-based therapeutics ... Read all


Boehringer Ingelheim
Philochem is a fully owned daughter company of Philogen and represents the Discovery Unit of the Philogen group.